Transactions

BioVie’s asset purchase of NeurMedix, Inc.

Date Announced:
04/27/2021

client:
Independent Committee of the Board of Directors of BioVie, Inc.

Status:
Closed – 06/11/2021

Value:
$122 million upfront and up to $3.1 billion total value